Inria, ANSSI, Capgemini, Dassault Systèmes, Inserm, Lunabee Studio, Orange, Santé Publique France and Withings create the StopCovid project team in order to structure and strengthen their contribution to the government project to set up a mobile contact tracing application (StopCovid). The purpose of this project is to provide the French health authorities with a complementary digital tool to help manage the sanitary emergency against Covid-19.
The French government has entrusted Inria with the operational management of the research and development project called “StopCovid”, which brings together the expertise of national players, both public and private, within the StopCovid project team. All these players are contributing to the work already under way to provide all French citizens with a tool to better protect them against Covid19.
Sharing the guidelines set by the Government, the project is based on five foundations:
The project is conducted under the supervision of the State and gives rise to regular interactions with independent control authorities, notably the CNIL (Commission Nationale de l’Informatique et des Libertés – French Data Protection Authority). It also involves DINUM (inter-ministerial directorate for digital).
The project, in its prototype construction phase, involves public and private organisations acting on a pro bono basis, as part of the StopCovid project team.
At European level, the project is also being carried out in close cooperation with national teams developing comparable applications in Germany, Great Britain, Italy, Spain and Norway, based on comparable approaches and ensuring interoperability.
Within the project, coordinated by Inria, the members of the StopCovid project team are involved in their field of expertise:
– Inria: coordination and transmission protocol, privacy-by-design;
– ANSSI: cybersecurity;
– Capgemini: back-end architecture and development;
– Dassault Systèmes: SecNumCloud qualified sovereign data infrastructure;
– Inserm: health models;
– Lunabee Studio: development of mobile applications;
– Orange: application distribution and interoperability;
– Santé Publique France: integration and coordination of the application in the global strategy of contact tracing;
– Withings: connected objects.
Alongside them, the entire ecosystem of research, innovation and companies is mobilized through the “ecosystem of StopCovid contributors“. Open, it brings together organizations or individuals who have shown their willingness to participate in the project, either through spontaneous contributions or in response to requests, whether through participation in technical expert groups, think tanks, provision of open source code, sharing of feedback on comparable solutions, or participation in field experiments.
“Inserm is participating in the development of this digital tool which will be a complement to the other elements necessary for a successful end of lock down (in particular the respect of hand hygiene and physical distancing): the digital tool will identify possible cases of Sars-cov infection, in order to be able to isolate them as quickly as possible, and help reduce the spread of the virus. It is therefore necessary to be able to go back to the chain of contacts of an infected person and identify any other people. This identification, in compliance with privacy and regulations, is all the more important as some contagious people ignore being infected. “
Dr Gilles Bloch, Inserm CEO
Inserm Research Director Alain Eychène is taking the helm at the French National Cancer Institute’s Research and Innovation division. In this new role, he will also head the Aviesan Multi-Organization Institute (ITMO) for cancer and will manage Inserm’s Cancer institute. ...
The Discovery trial was originally launched in March 2020 by Inserm to evaluate possible treatments for Covid-19. On January 13th, 2021, the Discovery Europe trial Data Safety Monitoring Boards (DSMB) evaluated an interim report based on 776 patients of whom 389 received ...